Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 332 across all filing types
Latest filing 2023-08-08 Regulatory Filings
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Contract Award
Regulatory Filings Classification · 1% confidence The document is clearly identified as an 'RNS Number' announcement from Physiomics PLC, dated August 8, 2023. The content announces a 'Contract award' with an existing client, Numab Therapeutics. This type of brief, time-sensitive corporate update, often distributed via the Regulatory News Service (RNS), fits the definition of a general regulatory announcement that doesn't specifically match other detailed categories like 10-K, ER, or DIV. Given its nature as a standard regulatory news service release, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements.
2023-08-08 English
Contract Award
Regulatory Filings Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 2825I' and contains an announcement titled 'Contract award' regarding a new contract won by Physiomics plc. The text is short (under 5,000 characters) and functions as a general regulatory announcement distributed via the RNS system. This fits the definition of a general regulatory announcement that doesn't fit a more specific category like ER, DIV, or CAP. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-08-04 English
Director Dealing
Director's Dealing Classification · 1% confidence The document is clearly identified as an RNS announcement (RNS Number : 0202H) dated 25 July 2023. The content explicitly details a 'Director Dealing' transaction involving the CEO, Dr Jim Millen, transferring shares to a nominee account. This falls directly under the definition of Director's Dealing (insider trades). Therefore, the appropriate code is DIRS.
2023-07-25 English
Director Dealing
Director's Dealing Classification · 1% confidence The document is titled 'Director Dealing' and contains a 'PDMR Notification Form' detailing a transaction by Dr Christophe Chassagnole, the Chief Operating Officer. PDMR (Persons Discharging Managerial Responsibilities) notifications are mandatory reports concerning insider trades or changes in holdings by directors/executives. This directly matches the definition for Director's Dealing (Code: DIRS). The presence of the RNS Number and the closing statement about RNS confirms it is a regulatory announcement, but the specific content points overwhelmingly to DIRS.
2023-07-18 English
Completion of Placing, Subscription & Retail Offer
Share Issue/Capital Change Classification · 1% confidence The document is an RNS announcement dated June 29, 2023, detailing the 'Completion of Fundraise' and the issuance of new Ordinary Shares, raising gross proceeds of £380,477. It also includes specific sections titled 'PDMR Notification Forms' detailing share subscriptions by the Executive Chairman and CEO (Dr Jim Millen) and the COO (Dr Christophe Chassagnole). The inclusion of PDMR (Persons Discharging Manager Duties) notifications strongly indicates insider trading or director dealing reports, which aligns with the definition of 'Director's Dealing' (DIRS). While it involves capital raising (CAP), the explicit inclusion of mandatory PDMR forms makes DIRS the most specific classification for this particular regulatory filing content, as it reports personal transactions by management.
2023-06-29 English
WRAP Retail Offer for up to £150,000
Capital/Financing Update Classification · 1% confidence The document is an official announcement released via RNS (RNS Number : 9709D) on June 27, 2023. The content explicitly details a 'WRAP Retail Offer for up to £150,000' through the issue of new ordinary shares, alongside an announcement of a Placing and intended Subscription. This activity directly relates to raising capital and issuing new shares. This fits the definition of 'Capital/Financing Update' (CAP) or potentially 'Share Issue/Capital Change' (SHA). Since the primary focus is announcing the mechanism and details of raising capital (£150,000 retail offer + £335,000 placing), 'Capital/Financing Update' (CAP) is the most precise fit for the overall event, although 'SHA' is also highly relevant as it involves issuing new shares. Given the context of fundraising, CAP is chosen. It is not a full report (10-K, IR) nor just a dividend notice or management change. It is a specific announcement about a financing event.
2023-06-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.